HSR proceedings in intensive care and cardiovascular anesthesia is an international journal dealing with intensive care anesthesia and major surgery topics. Cardiology, cardiac surgery, vascular surgery, echocardiography, new technologies, in-hospital emergencies, nursing, hematology, imaging and future events are among the major field of interest. There is also a peer-to-peer communication section. Critically ill patients management is the focus of our educational efforts. We publish original papers and review on these main topics.

home
HSR proceedings in intensive care and cardiovascular anesthesia

NEWS

January 2012

1st International Consensus Conference "Increasing survival in adult critically ill patients with or at risk of AKI"

Do you agree with the identified topics? Do you want to suggest new ones?

Please take one minute to cast your vote.

http://www.hsrproceedings.org/consensus/index.php?pag=topicselection

October 6th 2011

Roland Hetzer International Cardiothoracic and Vascular Surgery Society (RHICS)

To honor the mentorship, leadership and contributions of Prof. Dr. Roland Hetzer in the field of cardiothoracic and vascular surgery, the Roland Hetzer International Cardiothoracic and Vascular Surgery Society (RHICS) was founded by cardiothoracic and vascular surgeons who have trained and worked under Prof. Hetzer, including former students, present staff and colleagues from all over the world.

Its exclusive objectives are first of all to provide a forum for expert discussion on relevant cardiothoracic issues and to foster international collaboration and cooperation in clinical practice and scientific research in our specialty by setting up guidelines based on conclusions derived from this expert opinion forum.

June 2011

First International Consensus Conference on "Reducing perioperative mortality with drugs and non-surgical techniques/strategies" (any adult surgery)

14 drugs/techniques/strategies might reduce perioperative mortality in adult surgery (cardiac and/or non-cardiac surgery) while two ancillary (non-surgical) treatments might increase perioperative mortality.
Do you agree with the identified topics, manuscripts and statements of the first web-based International Consensus Conference?

Please take one minute to cast your vote, even if you already did it before June 9th.

Most read articles ever

Major themes for 2009 in cardiothoracic and vascular anesthesia

Fassl, H. Riha, H. Ramakrishna N. Singh, T. Wyckoff, C. Roscher, J.G.T. Augoustides

The hybrid operating room is the venue for transcatheter therapy with the convergence of three specialties: cardiac surgery, cardiovascular anesthesiology, and interventional cardiology. Transcatheter aortic valve replacement is proof that cardiac specialists have embraced the endovascular revolution. Since pharmacologic and ischemic myocardial conditioning are safe and effective, they are currently the focus of multiple trials. Angiotensin blockade, anemia and endoscopic saphenous vein harvesting worsen outcome after coronary artery bypass grafting (CABG). Although off-pump CABG is equivalent to on-pump CABG, it may improve outcomes in high-risk groups. Although percutaneous coronary intervention (PCI) significantly decreases mortality after myocardial infarction, the evidence is less convincing for intra-aortic balloon counterpulsation. Even though prasugrel was recently approved for platlet blockade in PCI, it may be superceded by ticagrelor. Although PCI and CABG appear equivalent for multivessel coronary disease, CABG lowers revascularization rates and also has superior outcomes in diabetics and the elderly. Hetastarch and N-acetylcysteine both increase bleeding and transfusion in cardiac surgery. Factor VII can treat life-threatening bleeding, but its safety requires further evaluation. Since eltrombopag and romiplostim stimulate platelet production, they may have a future role in hemostasis after cardiac surgery. Even though fenoldopam, atrial natriuretic peptide and sodium bicarbonate are nephroprotective, further trials must confirm these findings. Intensive insulin therapy offers no further outcome advantage and significantly increases hypoglycemic risk. The past year has witnessed the advent of a new clinical venue, new devices, and new drugs. The coming year will most likely advance these achievements.

"Once upon a time there was a congress..."

M. John

Carotid Endarterectomy: experience in 8743 cases

R. Chiesa, G. Melissano, R. Castellano, Y. Tshomba, E.M. Marone, E. Civilini, D.Astore, F. Calliari, B. Catenaccio, G. Coppi, A. Carozzo, R.Mennella

Where are italian anesthesiologists and intensive care specialists publishing? A quantitative analysis of publication activity

L. Buratti

Inter-hospital extracorporeal life support

G. Redaelli, A. Annoni, R. Caruso, F. Formica, V. Meroni, L. Avalli